Overview

Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL

Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
To explore the efficiency and safety of CLAG regimen in R/R ALL
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Collaborators:
Suzhou Municipal Hospital
The First People's Hospital of Changzhou
Zhongda Hospital
Treatments:
Cladribine
Cytarabine
Fludarabine
Methotrexate